COVID-19 test kit xMAP®

for antibodiesIgGSARS-COV-2

In these uncertain times, laboratories need to have confidence in COVID-19 antibody test results—which is why Luminex has developed a comprehensive SARS-CoV-2 antibody assay. Using a combination of robust internal controls and highly-specific antigens, the xMAP® SARS-CoV-2 assay enables the rapid and reliable detection of SARS-CoV-2 antibodies in plasma and serum samples. The xMAP® SARS-CoV-2 Multi-Antigen IgG Assay (RUO) is a multiplex, microsphere-based, highly sensitive and specific assay that detects the presence or absence of antibodies against three different SARS-CoV-2 antigens. The xMAP SARS-CoV-2 Multi-Antigen IgG Assay features: Broad Coverage: Detects IgG antibodies against 3 SARS-CoV-2 antigens, providing comprehensive results: S1 subunit of the spike protein Receptor Binding Domain (RBD) of the spike protein Nucleocapsid protein Flexible Throughput: Test up to 96 samples per run in less than 3 hours to meet your throughput needs. Versatile System Options: Can be used on MAGPIX®, Luminex® 200™, and FLEXMAP 3D® Systems, so you can use the platform that best fits your lab. Common Sample Types: Designed for use with plasma and serum samples, eliminating the need to implement additional collection protocols. xMAP® SARS-CoV-2 Multi-Antigen IgG Assay Workflow Step 1 Add sample and bead mix to the well and incubate for 60 min at room temperature. Step 2 Add detection antibody mix to the well and incubate for 60 min at room temperature. Step 3 Resuspend sample and transfer plate to instrument. Step 4 Read on Luminex Instrument.